» Articles » PMID: 26721601

Cigarette Smoking Behaviour and Blood Metabolomics

Abstract

Background: Identifying circulating metabolites related to cigarette smoking may provide insight into the biological mechanisms of smoking-related diseases and the nature of addiction. However, previous studies are limited, generally small, and have largely targeted a priori metabolites.

Methods: We examined associations between cigarette smoking and metabolites using an untargeted metabolomics approach in 892 men and women from four studies including participants from Italy, USA, China and Finland. We examined associations between individual log-transformed metabolites and two key smoking phenotypes (current smoking status and cigarettes per day [cig/day]) using linear regression. Fixed-effect meta-analysis was used to combine results across studies. Strict Bonferroni thresholds were used as our significance criteria. We further examined associated metabolites with other metrics of smoking behaviuor (current versus former, former versus never, smoking duration and years since quitting) in the US study.

Results: We identified a total of 25 metabolites associated with smoking behaviours; 24 were associated with current smoking status and eight with cig/day. In addition to three well-established nicotine metabolites (cotinine, hydroxycotinine, cotinine N-oxide), we found an additional 12 xenobiotic metabolites involved in benzoatic (e.g. 3-ethylphenylsulphate) or xanthine metabolism (e.g. 1-methylurate), three amino acids (o-cresol sulphate, serotonin, indolepropionate), two lipids (scyllo-inositol, pregnenolone sulphate), four vitamins or cofactors [e.g. bilirubin (Z,Z)], and one carbohydrate (oxalate).

Conclusions: We identified associations between cigarette smoking and a diverse range of metabolites. Our findings, with further validation in future studies, have implications regarding aetiology and study design of smoking-related diseases.

Citing Articles

Blood metabolites, neurocognition and psychiatric disorders: a Mendelian randomization analysis to investigate causal pathways.

Guo J, Yang P, Wang J, Tang S, Han J, Yao S Transl Psychiatry. 2024; 14(1):376.

PMID: 39285197 PMC: 11405529. DOI: 10.1038/s41398-024-03095-4.


[Study on the difference and clinical value of serum amino acids in patients with laryngeal squamous cell carcinoma].

Sun Y, Gan M, Wu Y, Gao W, Lu Y Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024; 38(8):715-721.

PMID: 39118510 PMC: 11612755. DOI: 10.13201/j.issn.2096-7993.2024.08.008.


Metabolomics-based search for lung cancer markers among patients with different smoking status.

Klupczynska-Gabryszak A, Daskalaki E, Wheelock C, Kasprzyk M, Dyszkiewicz W, Grabicki M Sci Rep. 2024; 14(1):15444.

PMID: 38965272 PMC: 11224321. DOI: 10.1038/s41598-024-65835-2.


Pathophysiology and genomics of bronchiectasis.

Perea L, Faner R, Chalmers J, Sibila O Eur Respir Rev. 2024; 33(173).

PMID: 38960613 PMC: 11220622. DOI: 10.1183/16000617.0055-2024.


The Metabolomic Profile of Microscopic Colitis Is Affected by Smoking but Not Histopathological Diagnosis, Clinical Course, Symptoms, or Treatment.

Strom A, Stenlund H, Ohlsson B Metabolites. 2024; 14(6).

PMID: 38921438 PMC: 11205623. DOI: 10.3390/metabo14060303.


References
1.
Rappaport S, Barupal D, Wishart D, Vineis P, Scalbert A . The blood exposome and its role in discovering causes of disease. Environ Health Perspect. 2014; 122(8):769-74. PMC: 4123034. DOI: 10.1289/ehp.1308015. View

2.
Ma K, Thomason L, McLaurin J . scyllo-Inositol, preclinical, and clinical data for Alzheimer's disease. Adv Pharmacol. 2012; 64:177-212. DOI: 10.1016/B978-0-12-394816-8.00006-4. View

3.
Gu F, Caporaso N, Schairer C, Fortner R, Xu X, Hankinson S . Urinary concentrations of estrogens and estrogen metabolites and smoking in caucasian women. Cancer Epidemiol Biomarkers Prev. 2012; 22(1):58-68. PMC: 3643002. DOI: 10.1158/1055-9965.EPI-12-0909. View

4.
Moore S, Matthews C, Sampson J, Stolzenberg-Solomon R, Zheng W, Cai Q . Human metabolic correlates of body mass index. Metabolomics. 2014; 10(2):259-269. PMC: 4169991. DOI: 10.1007/s11306-013-0574-1. View

5.
Weimann A, Sabroe M, Poulsen H . Measurement of caffeine and five of the major metabolites in urine by high-performance liquid chromatography/tandem mass spectrometry. J Mass Spectrom. 2005; 40(3):307-16. DOI: 10.1002/jms.785. View